Chickadee Biomedicines, Inc.
New Form D on file · 2026-11-10 · the record
Before you sell to, join or invest in Chickadee Biomedicines, Inc.
MentionFox check on Chickadee Biomedicines, Inc.: only 1 source on file so far (checked 13 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/chickadee-biomedicines-inc-form-d-000003
Check Chickadee Biomedicines, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Chickadee Biomedicines, Inc. filed a Form D with the Securities and Exchange Commission on 2026-11-10.
Chickadee Biomedicines, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 10, 2026. The filing reports $1M sold. Its industry group is Biotechnology. It names Weining Lu (Executive Officer, Director, Promoter), Goran Dolsten (Executive Officer, Director, Promoter), Patrick Doyle (Executive Officer, Director) (SEC Form D, November 10, 2026).
Sell to companies like Chickadee Biomedicines, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Chickadee Biomedicines, Inc. raised on Nov 10. 88 companies raised this week, 1 had other signals.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| fal - Features & Labels, Inc. | $1B | AI and software |
| fal - Features & Labels, Inc. | $350M | AI and software |
| SIERRA INTERNATIONAL NETWORK INC | $300M | AI and software |
| Zai Lab Ltd | $250M | Biotech |
| Databento Inc. | $100M | AI and software |
Selling to Chickadee Biomedicines, Inc.? See who runs it and how to reach them, plus this week's 84 other newly funded companies.
Is this your company?
New Form D on file · 2026-11-10 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Chickadee Biomedicines, Inc.
Free to see. No signup.
More on the people and the money behind Chickadee Biomedicines, Inc., from the filings we hold.
Biotechnology raises by companies based in New York, filed within 90 days of this one, largest first.
Get an email when Chickadee Biomedicines, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Chickadee Biomedicines, Inc. raises, hires or launches. No email unless you switch it on.
Watch Chickadee Biomedicines, Inc. →Get the full cited report on Chickadee Biomedicines, Inc.
What the filing shows about Chickadee Biomedicines, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Chickadee Biomedicines, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The weeks after a raise are when investors, other founders and press look Chickadee Biomedicines, Inc. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on Chickadee Biomedicines, Inc.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.
The filing gives Chickadee Biomedicines, Inc.'s address as 626 1ST Avenue, #W26H, New York, NY 10016.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Chickadee Biomedicines, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Chickadee Biomedicines, Inc. See pricing
Chickadee Biomedicines, Inc. is a registered filer with the SEC (CIK 2138882) and has filed since 2026-06-25. 2 filings are on record, the latest on 2026-11-10.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Chickadee Biomedicines, Inc.'s Form D of 2026-11-10 names Weining Lu, Goran Dolsten and Patrick Doyle as its officers, directors or promoters.
Its new offerings report $1.15M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 757 filings in Biotechnology, totalled by week. The dot is this raise, $1M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Proceeds will be used for Issuer's general corporate and working capital purposes, which will include payment of salary of executive officer in the ordinary course of business as disclosed to investors.
Weining Lu is named as Executive Officer and Director and Promoter on the Form D that Chickadee Biomedicines, Inc. filed with the SEC on 10 November 2026, one of 3 people that filing names.
Goran Dolsten is named as Executive Officer and Director and Promoter on the Form D that Chickadee Biomedicines, Inc. filed with the SEC on 10 November 2026, one of 3 people that filing names.
Patrick Doyle is named as Executive Officer and Director on the Form D that Chickadee Biomedicines, Inc. filed with the SEC on 10 November 2026, one of 3 people that filing names.
3 people named on the filing — 3 holding an executive role.
Named as of the 2026-11-10 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Chickadee Biomedicines, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Chickadee Biomedicines, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Chickadee Biomedicines, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
3 people named on this filing See who they are
Start a free 5-day trial →You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Chickadee Biomedicines, Inc.You get an alert in MentionFox the next time this company shows up.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Chickadee Biomedicines, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises, week of 2026-11-09 · Biotech raises in New York
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

https://mentionfox.com/funding/chickadee-biomedicines-inc-form-d-000003